Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	360.95	-167.01	36.23
Graham Fair Price	31.66	25.60	19.45
PEG	-79.34	0.13	-0.62
Price/Book	6.36	1.14	1.08
Price/Cash Flow	206.89	70.70	23.04
Prices/Earnings	-41.11	11.53	19.59
Price/Sales	-48.68	6.38	12.43
Price/FCF	206.89	70.70	23.04
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	11.23	0.91	0.82
Operating Margin	-40.05	0.21	0.35
ROA	76.93	< 0.005	< 0.005
ROE	0.01	0.02	80.61
ROIC	0.02	0.02	15.71
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.14	-0.21	-37.10
Dividends QOQ	< 0.005	< 0.005	60.16
EBIT QOQ	-0.17	0.22	30.15
EPS QOQ	-0.32	0.90	184.98
FCF QOQ	-0.19	-0.66	-251.89
Revenue QOQ	-0.07	1.03	1327.03
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	-1249.53	0.00	inf
Days Sales Outstanding (DSO)	101.40	0.00	inf
Inventory Turnover	-0.07	0.00	inf
Debt/Capitalization	0.27	0.32	18.33
Quick Ratio	3617.29	0.42	-99.99
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	34.98	34.27	-2.03
Cash	82.99	82.46	-0.64
Capex	-0.08	-0.13	-58.65
Free Cash Flow	1.63	0.55	-66.05
Revenue	3.03	6.15	103.02
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	3490.49	0.17	-100.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-2.01	-0.94	52.90
Naive Interpretation	Member

06 - Financial Health · Bad

Rating